The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.

RecruitingOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Melanoma of Skin

Trial Locations (1)

RECRUITING

University Hospital Carl Gustav Carus, Dresden

All Listed Sponsors

collaborator

University Hospital Carl Gustav Carus

OTHER

lead

Technische Universität Dresden

OTHER